Comorbidities to Breast Cancer

The most prevalent comorbidities related to carcinoma are hypertension (21.8%), chronic obstructive pulmonary disease (COPD) (19.9%), rheumatologic disease (18.6%), and diabetes (16.7%), all four conditions are reported in around 75% of the cases.

Pre-existing comorbidities negatively impacts overall carcinoma prognosis, increasing both carcinoma specific deaths furthermore as death from competing causes. Improvements in carcinoma survival in recent decades, however, have primarily been experienced among cancer patients without comorbidities, and fewer so among those with moderate or severe comorbidities. Information regarding treatment effectiveness in carcinoma patients with comorbidities is currently lacking. This chapter describes the impact of comorbidities on carcinoma treatment and outcomes, previous research approaches taken, and specific populations that will be most prone to the results of comorbidities on carcinoma outcomes. Future research directions are suggested that will help to enhance understanding of comorbidity-related factors that underlie disparities in carcinoma outcomes, and to look at the potential role of effective management of comorbidities among carcinoma patients as a method to assist close gaps in disease prognosis.

 

    Related Conference of Comorbidities to Breast Cancer

    October 27-27, 2021

    3rd Webinar on Oncology and Radiology

    London, UK
    October 28-29, 2021

    5th Global Summit on Cancer

    Tokyo, Japan
    November 11-12, 2021

    6th Global summit on Cancer Science and Oncology

    Paris, France
    November 15-16, 2021

    11th International Conference on Cancer & Tumor Immunology

    Amsterdam, Netherlands
    November 15-16, 2021

    7th World Summit on Cancer Science and Oncology

    London, UK
    November 18-18, 2021

    35th International Conference on Cancer Science & Therapy

    Singapore City, Singapore
    November 22-23, 2021

    9th Annual Congress on Pulmonary and Critical Care

    Singapore City,Singapore
    December 05-06, 2021

    5th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    February 10-11, 2022

    4th Asia Pacific Oncology and Cancer Conference

    Stockholm, Sweden
    March 11-12, 2022

    33rd Experts Meet On Cancer Research & Therapy

    Singapore City, Singapore
    March 14-15, 2022

    12th World Congress on Breast Cancer

    London, UK
    March 24-25, 2022

    8th International Conference on Neuro-Oncology and Brain Tumor

    Singapore City, Singapore
    April 04-05, 2022

    3rd Global Summit on Oncology and Hematology

    Rome, Italy
    April 18-19, 2022

    42nd Annual Summit on Oncology and Cancer

    Miami, USA
    April 18-19, 2022

    Annual Conference on Cancer Research

    Miami, USA
    April 26-27, 2022

    23rd World Congress on Pediatric & neonatal Oncology

    Yokohama, Japan
    May 23-24, 2022

    12th World Congress on Breast Cancer Research & Therapies

    Melbourne, Australia
    May 25-26, 2022

    International Conference on Oncology and Radiology

    Zurich, Switzerland
    June 13-14, 2022

    21st World Congress on Gastrointestinal Cancer

    Amsterdam, Netherlands
    July 13-14, 2022

    5th Cancer Diagnostics & Treatment Conference

    Vancouver, Canada
    September 21-22, 2022

    21st Global Cancer Summit

    Tokyo, Japan

    Comorbidities to Breast Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in